Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Infectiousness and treatment as prevention news

Show

From To
Modern HIV Prevention: What’s Next For Women?

The vaginal ring is one more addition to an already exciting array of antiretroviral-based biomedical options in the prevention toolbox that has ushered in a new era in HIV prevention.

Published
26 February 2016
From
International AIDS Society
Very high levels of chemsex and ‘slamsex’ seen in HIV-positive men attending English/Welsh HIV clinics

A survey of HIV-positive patients attending 30 HIV clinics in England and Wales, presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2016), has found

Published
24 February 2016
By
Gus Cairns
People with HIV considerably overestimate their chance of infecting someone

Only a small proportion of HIV-positive people in a large US treatment study, ACTG A5257, regarded themselves as non-infectious after up to three years on antiretroviral therapy (ART),

Published
24 February 2016
By
Gus Cairns
Discovering Your Sexual Personality In a New Era of HIV

For the first time in generations, we have a chance to reclaim our sexual personality. For so long, sex brought death; now, sex can bring us to life again. Bur first, we have to re-teach our emotional brains. We have to break free from our chains and re-imagine our sexuality. How can we do this?

Published
20 February 2016
From
BETA blog
HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

A group of researchers have cleared up an important question about HIV transmission, in experiments on mice. Although HIV-infected CD4 cells persist in the vagina even on

Published
15 February 2016
By
Gus Cairns
Dumbing down HIV treatment hurts everybody

Bob Leahy says there is so much faulty information on what being on treatment means and when to start that it is hurting us all. But there are solutions which can successfully balance patient rights with the benefits of starting treatment early.

Published
11 February 2016
From
Positive Lite
Activists United and Ignited by Urgency for HIV Prevention in Europe: EATG and AVAC call for the rollout of PrEP as a proven HIV prevention strategy

Initiated and organised entirely by the community of people living with and at risk for HIV, the second European HIV Prevention Summit brought together representatives of civil society, the pharmaceutical industry, researchers and academia in Brussels between 29 and 31 January. In addition to a thorough examination of PrEP (pre-exposure prophylaxis), the summit discussed the latest developments in the research fields of vaccines, rectal and vaginal microbicides and antibodies and their utility in HIV prevention.

Published
03 February 2016
From
EATG
HIV is not transmitted under fully suppressive therapy: The Swiss Statement – eight years later

In summary, in the past eight years one randomised and two on-going observational trials continue to support the “no-risk” hypothesis of the Swiss statement, while the basis for the statement – the absence of observed cases – has further increased over time. Perhaps the most important legacy of the Swiss statement has been the empowerment of people living with HIV.

Published
30 January 2016
From
Swiss Medical Weekly
Where next for HIV prevention in New Zealand?

A key focus of the New Zealand Medical Journal editorial is on the continued importance of behaviour-based interventions in a world where the momentum seems to have shifted to clinic based control involving pharmaceuticals. The authors highlight the danger that the medicalization of HIV prevention could lead to a disinvestment in behaviour-based interventions, which, they imply, would not be conducive to controlling the epidemic.

Published
30 January 2016
From
BMJ Group blogs
Two cases of PrEP failure on solo tenofovir pose significant research questions

A report originally presented to the 2015 BHIVA conference last year details two cases where therapeutic levels of solo tenofovir unequivocally failed to prevent HIV infection in

Published
14 January 2016
By
Gus Cairns

Filter by country